Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms

References

• Mitchison DA. The diagnosis and therapy of tuberculosis during the past 100 years. Am. J. Respir. Crit. Care Med. 171(7), 699–706 (2005).
   PubMed Web of Science ®Google Scholar
• BMC. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1(7760), 1079–1085 (1972).
   PubMed Web of Science ®Google Scholar
• Dye C, Lönnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull. World Health Organ. 87(9), 683–691 (2009).
   PubMed Web of Science ®Google Scholar
• Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int. J. Tuberc. Lung Dis. 2(1), 10–15 (1998).
   PubMed Web of Science ®Google Scholar
• Ormerod LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br. Med. Bull 73, 17–24 (2005).
   PubMed Web of Science ®Google Scholar
• Harrington M. From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. Clin. Infect. Dis. 50(Suppl. 3), S260–S266 (2010).
   PubMedGoogle Scholar
• Aaron L, Saadoun D, Calatroni I et al. Tuberculosis in HIV-infected patients: a comprehensive review. Clin. Microbiol. Infect. 10(5), 388–398 (2004).
   PubMed Web of Science ®Google Scholar
• Jindani A, Doré CJ, Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am. J. Respir. Crit. Care Med. 167(10), 1348–1354 (2003).
   PubMed Web of Science ®Google Scholar
• Dubos RJ, Middlebrook G. The effect of wetting agents on the growth of tubercle bacilli. J. Exp. Med. 88(1), 81–88 (1948).
   PubMedGoogle Scholar
• Van Boxtel RM, Lambrecht RS, Collins MT. Effects of colonial morphology and Tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis. Antimicrob. Agents Chemother. 34(12), 2300–2303 (1990).
   PubMedGoogle Scholar
• Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28(2), 546–556 (1980).
   PubMed Web of Science ®Google Scholar
• Costerton JW, Irvin RT, Cheng KJ. The role of bacterial surface structures in pathogenesis. Crit. Rev. Microbiol. 8(4), 303–338 (1981).
   PubMed Web of Science ®Google Scholar
• Kolter R, Losick R. One for all and all for one. Science 280(5361), 226–227 (1998).
   PubMed Web of Science ®Google Scholar
• Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 9(6), 588–594 (2006).
   PubMed Web of Science ®Google Scholar
• Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56, 187–209 (2002).
   PubMed Web of Science ®Google Scholar
• Hogan DA, Kolter R. Pseudomonas candida interactions: an ecological role for virulence factors. Science 296(5576), 2229–2232 (2002).
   PubMed Web of Science ®Google Scholar
• Allison DG. The biofilm matrix. Biofouling 19(2), 139–150 (2003).
   PubMed Web of Science ®Google Scholar
• Branda SS, Vik S, Friedman L, Kolter R. Biofilms: the matrix revisited. Trends Microbiol. 13(1), 20–26 (2005).
   PubMed Web of Science ®Google Scholar
• Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Harris JK, Pace NR. Opportunistic pathogens enriched in showerhead biofilms. Proc. Natl. Acad. Sci. USA 106(38), 16393–16399 (2009).
   PubMed Web of Science ®Google Scholar
• Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol. 13(1), 34–40 (2005).
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. 13(1), 7–10 (2005).
   PubMed Web of Science ®Google Scholar
• Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6(3), 199–210 (2008).
   PubMed Web of Science ®Google Scholar
• Vlamakis H, Aguilar C, Losick R, Kolter R. Control of cell fate by the formation of an architecturally complex bacterial community. Genes Dev. 22(7), 945–953 (2008).
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 284(5418), 1318–1322 (1999).
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2), 167–193 (2002).
   PubMed Web of Science ®Google Scholar
• Danese PN, Pratt LA, Dove SL, Kolter R. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol. Microbiol. 37(2), 424–432 (2000).
   PubMed Web of Science ®Google Scholar
• Chen JM, German GJ, Alexander DC, Ren H, Tan T, Liu J. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J. Bacteriol. 188(2), 633–641 (2006).
   PubMed Web of Science ®Google Scholar
• Hinsa SM, Espinosa-Urgel M, Ramos JL, O’Toole GA. Transition from reversible to irreversible attachment during biofilm formation by Pseudomonas fluorescens WCS365 requires an ABC transporter and a large secreted protein. Mol. Microbiol. 49(4), 905–918 (2003).
   PubMedGoogle Scholar
• Kolter R, Greenberg EP. Microbial sciences: the superficial life of microbes. Nature 441(7091), 300–302 (2006).
   PubMed Web of Science ®Google Scholar
• O’Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB, Kolter R. Genetic approaches to study of biofilms. Meth. Enzymol. 310, 91–109 (1999).
   PubMed Web of Science ®Google Scholar
• Carman ML, Estes TG, Feinberg AW et al. Engineered antifouling microtopographies – correlating wettability with cell attachment. Biofouling 22(1-2), 11–21 (2006).
   PubMed Web of Science ®Google Scholar
• Nudleman E, Kaiser D. Pulling together with type IV pili. J. Mol. Microbiol. Biotechnol. 7(1–2), 52–62 (2004).
   PubMedGoogle Scholar
• Proft T, Baker EN. Pili in Gram-negative and Gram-positive bacteria – structure, assembly and their role in disease. Cell. Mol. Life Sci. 66(4), 613–635 (2009).
   PubMed Web of Science ®Google Scholar
• Ogasawara H, Yamamoto K, Ishihama A. Role of the biofilm master regulator CsgD in cross-regulation between biofilm formation and flagellar synthesis. J. Bacteriol. 193(10), 2587–2597 (2011).
   PubMed Web of Science ®Google Scholar
• Cotter PA, Stibitz S. c-di-GMP-mediated regulation of virulence and biofilm formation. Curr. Opin. Microbiol. 10(1), 17–23 (2007).
   PubMed Web of Science ®Google Scholar
• Hammer BK, Bassler BL. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol. Microbiol. 50(1), 101–104 (2003).
   PubMed Web of Science ®Google Scholar
• Higgins DA, Pomianek ME, Kraml CM, Taylor RK, Semmelhack MF, Bassler BL. The major Vibrio cholerae autoinducer and its role in virulence factor production. Nature 450(7171), 883–886 (2007).
   PubMed Web of Science ®Google Scholar
• Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280(5361), 295–298 (1998).
   PubMed Web of Science ®Google Scholar
• Kearns DB, Chu F, Branda SS, Kolter R, Losick R. A master regulator for biofilm formation by Bacillus subtilis. Mol. Microbiol. 55(3), 739–749 (2005).
   PubMed Web of Science ®Google Scholar
• Chu F, Kearns DB, Branda SS, Kolter R, Losick R. Targets of the master regulator of biofilm formation in Bacillus subtilis. Mol. Microbiol. 59(4), 1216–1228 (2006).
   PubMed Web of Science ®Google Scholar
• Chai Y, Chu F, Kolter R, Losick R. Bistability and biofilm formation in Bacillus subtilis. Mol. Microbiol. 67(2), 254–263 (2008).
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2(2), 95–108 (2004).
   PubMed Web of Science ®Google Scholar
• Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186(24), 8172–8180 (2004).
   PubMed Web of Science ®Google Scholar
• Mah TF, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9(1), 34–39 (2001).
   PubMed Web of Science ®Google Scholar
• McNeill K, Hamilton IR. Acid tolerance response of biofilm cells of Streptococcus mutans. FEMS Microbiol. Lett. 221(1), 25–30 (2003).
   PubMedGoogle Scholar
• Teitzel GM, Parsek MR. Heavy metal resistance of biofilm and planktonic Pseudomonas aeruginosa. Appl. Environ. Microbiol. 69(4), 2313–2320 (2003).
   PubMed Web of Science ®Google Scholar
• Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47(1), 317–323 (2003).
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Stoodley P. Developmental regulation of microbial biofilms. Curr. Opin. Biotechnol. 13(3), 228–233 (2002).
   PubMed Web of Science ®Google Scholar
• Lazazzera BA. Lessons from DNA microarray analysis: the gene expression profile of biofilms. Curr. Opin. Microbiol. 8(2), 222–227 (2005).
   PubMed Web of Science ®Google Scholar
• Gilbert P, Allison DG, McBain AJ. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? Symp. Ser. Soc. Appl. Microbiol. 31, 98S–110S (2002).
   Google Scholar
• Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. The role of biofilms in otolaryngologic infections. Curr. Opin. Otolaryngol. Head Neck Surg. 12(3), 185–190 (2004).
   PubMedGoogle Scholar
• Sbordone L, Bortolaia C. Oral microbial biofilms and plaque-related diseases: microbial communities and their role in the shift from oral health to disease. Clin. Oral Investig. 7(4), 181–188 (2003).
   PubMed Web of Science ®Google Scholar
• Yoon SS, Hennigan RF, Hilliard GM et al. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3(4), 593–603 (2002).
   PubMed Web of Science ®Google Scholar
• Marrie TJ, Nelligan J, Costerton JW. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 66(6), 1339–1341 (1982).
   PubMed Web of Science ®Google Scholar
• Anderson GG, Dodson KW, Hooton TM, Hultgren SJ. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol. 12(9), 424–430 (2004).
   PubMed Web of Science ®Google Scholar
• Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35(4), 322–332 (2010).
   PubMed Web of Science ®Google Scholar
• Jensen PØ, Givskov M, Bjarnsholt T, Moser C. The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol. Med. Microbiol. 59(3), 292–305 (2010).
   PubMed Web of Science ®Google Scholar
• Van Gennip M, Christensen LD, Alhede M et al. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS 117(7), 537–546 (2009).
   PubMedGoogle Scholar
• Moss RB, Hsu YP, Olds L. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin. Exp. Immunol. 120(3), 518–525 (2000).
   PubMed Web of Science ®Google Scholar
• Leid JG, Shirtliff ME, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect. Immun. 70(11), 6339–6345 (2002).
   PubMed Web of Science ®Google Scholar
• Prabhakara R, Harro JM, Leid JG, Harris M, Shirtliff ME. Murine immune response to a chronic Staphylococcus aureus biofilm infection. Infect. Immun. 79(4), 1789–1796 (2011).
   PubMed Web of Science ®Google Scholar
• Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Høiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 108(5), 329–335 (2000).
   PubMed Web of Science ®Google Scholar
• Saginur R, Stdenis M, Ferris W et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob. Agents Chemother. 50(1), 55–61 (2006).
   PubMed Web of Science ®Google Scholar
• Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37(6), 1771–1776 (1999).
   PubMed Web of Science ®Google Scholar
• Banin E, Brady KM, Greenberg EP. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl. Environ. Microbiol. 72(3), 2064–2069 (2006).
   PubMed Web of Science ®Google Scholar
• Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R, Losick R. d-amino acids trigger biofilm disassembly. Science 328(5978), 627–629 (2010).
   PubMed Web of Science ®Google Scholar
• Canetti G, Gay P, Le Lirzin M. Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey. Tubercle 53(2), 57–83 (1972).
   PubMedGoogle Scholar
• Lenaerts AJ, Hoff D, Aly S et al. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910. Antimicrob. Agents Chemother. 51(9), 3338–3345 (2007).
   PubMed Web of Science ®Google Scholar
• Alteri CJ, Xicohténcatl-Cortes J, Hess S, Caballero-Olín G, Girón JA, Friedman RL. Mycobacterium tuberculosis produces pili during human infection. Proc. Natl. Acad. Sci. USA 104(12), 5145–5150 (2007).
   PubMed Web of Science ®Google Scholar
• Gill WP, Harik NS, Whiddon MR, Liao RP, Mittler JE, Sherman DR. A replication clock for Mycobacterium tuberculosis. Nat. Med. 15(2), 211–214 (2009).
   PubMed Web of Science ®Google Scholar
• Barry CE 3rd, Boshoff HI, Dartois V et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7(12), 845–855 (2009).
   PubMed Web of Science ®Google Scholar
• Rhoades ER, Geisel RE, Butcher BA, McDonough S, Russell DG. Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components. Tuberculosis (Edinb). 85(3), 159–176 (2005).
   PubMedGoogle Scholar
• Lin PL, Flynn JL. Understanding latent tuberculosis: a moving target. J. Immunol. 185(1), 15–22 (2010).
   PubMed Web of Science ®Google Scholar
• Ford CB, Lin PL, Chase MR et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43(5), 482–486 (2011).
   PubMed Web of Science ®Google Scholar
• Yong DB, Gideon HP, Wilkinson RJ. Eliminating latent tuberculosis. Trends Microbiol. 17(15), 183–188 (2009).
   PubMedGoogle Scholar
• Ulrichs T, Kosmiadi GA, Jörg S et al. Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J. Infect. Dis. 192(1), 89–97 (2005).
   PubMedGoogle Scholar
• Lazarevic V, Nolt D, Flynn JL. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J. Immunol. 175(2), 1107–1117 (2005).
   PubMedGoogle Scholar
• Young DB, Gideon HP, Wilkinson RJ. Eliminating latent tuberculosis. Trends Microbiol. 17(5), 183–188 (2009).
   PubMed Web of Science ®Google Scholar
• Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6(3), 107–112 (1998).
   PubMed Web of Science ®Google Scholar
• Gomez JE, McKinney JD. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb.) 84(1-2), 29–44 (2004).
   PubMed Web of Science ®Google Scholar
• Medlar EM, Bernstein S, Steward DM. A bacteriologic study of resected tuberculous lesions. Am. Rev. Tuberc. 66(1), 36–43 (1952).
   PubMedGoogle Scholar
• Loring WE, Vandiviere HM. The treated pulmonary lesion and its tubercle bacillus. I. Pathology and pathogenesis. Am. J. Med. Sci. 232(1), 20–29 (1956).
   PubMedGoogle Scholar
• Loring WW, Melvin I, Vandiviere HM, Willis HS. The death and resurrection of the tubercle bacillus. Trans. Am. Clin. Climatol. Assoc. 67, 132–138 (1955).
   PubMedGoogle Scholar
• McCune RM, Feldmann FM, Lambert HP, McDermott W. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med. 123(3), 445–468 (1966).
   PubMed Web of Science ®Google Scholar
• Mccune RM Jr, Mcdermott W, Tompsett R. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104(5), 763–802 (1956).
   PubMed Web of Science ®Google Scholar
• Haapanen JH, Kass I, Gensini G, Middlebrook G. Studies on the gaseous content of tuberculous cavities. Am. Rev. Respir. Dis. 80(Part 1), 1–5 (1959).
   PubMedGoogle Scholar
• Vandiviere HM, Loring WE, Melvin I, Willis S. The treated pulmonary lesion and its tubercle bacillus. II. The death and resurrection. Am. J. Med. Sci. 232(1), 30–37; passim (1956).
   PubMedGoogle Scholar
• Via LE, Lin PL, Ray SM et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76(6), 2333–2340 (2008).
   PubMed Web of Science ®Google Scholar
• Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64(6), 2062–2069 (1996).
   PubMed Web of Science ®Google Scholar
• Rustad TR, Harrell MI, Liao R, Sherman DR. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3(1), e1502 (2008).
   PubMed Web of Science ®Google Scholar
• Park HD, Guinn KM, Harrell MI et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48(3), 833–843 (2003).
   PubMed Web of Science ®Google Scholar
• Morris RP, Nguyen L, Gatfield J et al. Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 102(34), 12200–12205 (2005).
   PubMed Web of Science ®Google Scholar
• Baek SH, Li AH, Sassetti CM. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol. 9(5), e1001065 (2011).
   PubMed Web of Science ®Google Scholar
• Aldridge BB, Fernandez-Suarez M, Heller D et al. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 335(6064), 100–104 (2012).
   PubMed Web of Science ®Google Scholar
• Nikaido H, Jarlier V. Permeability of the mycobacterial cell wall. Res. Microbiol. 142(4), 437–443 (1991).
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Brun OS, Polshyna G, Barker LP. Mycobacterium marinum biofilm formation reveals cording morphology. FEMS Microbiol. Lett. 257(1), 43–49 (2006).
   PubMed Web of Science ®Google Scholar
• Bosio S, Leekha S, Gamb SI, Wright AJ, Terrell CL, Miller DV. Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms. Cardiovasc. Pathol. 21(4), 361–364 (2012).
   PubMedGoogle Scholar
• Feazel LM, Baumgartner LK, Peterson KL et al. Opportunistic pathogens enriched in showerhead biofilms. Proc. Natl. Acad. Sci. USA 106(38), 16393–16399 (2009).
   PubMed Web of Science ®Google Scholar
• Cook KL, Britt JS, Bolster CH. Survival of Mycobacterium avium subsp. paratuberculosis in biofilms on livestock watering trough materials. Vet. Microbiol. 141(1–2), 103–109 (2010).
   PubMed Web of Science ®Google Scholar
• Recht J, Kolter R. Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis. J. Bacteriol. 183(19), 5718–5724 (2001).
   PubMedGoogle Scholar
• Yamazaki Y, Danelishvili L, Wu M, Macnab M, Bermudez LE. Mycobacterium avium genes associated with the ability to form a biofilm. Appl. Environ. Microbiol. 72(1), 819–825 (2006).
   PubMedGoogle Scholar
• Ojha AK, Baughn AD, Sambandan D et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 69(1), 164–174 (2008).
   PubMed Web of Science ®Google Scholar
• Ojha AK, Trivelli X, Guerardel Y, Kremer L, Hatfull GF. Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms. J. Biol. Chem. 285(23), 17380–17389 (2010).
   PubMedGoogle Scholar
• Ojha A, Anand M, Bhatt A, Kremer L, Jacobs WR Jr, Hatfull GF. GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell 123(5), 861–873 (2005).
   PubMed Web of Science ®Google Scholar
• Ojha A, Hatfull GF. The role of iron in Mycobacterium smegmatis biofilm formation: the exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth. Mol. Microbiol. 66(2), 468–483 (2007).
   PubMed Web of Science ®Google Scholar
• Banin E, Vasil ML, Greenberg EP. Iron and Pseudomonas aeruginosa biofilm formation. Proc. Natl. Acad. Sci. USA 102(31), 11076–11081 (2005).
   PubMed Web of Science ®Google Scholar
• Pang JM, Layre E, Sweet L et al. The polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosis. J. Bacteriol. 194(3), 715–721 (2012).
   PubMed Web of Science ®Google Scholar
• Marsollier L, Aubry J, Coutanceau E et al. Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmatocytes and a macrolide toxin, mycolactone. Cell. Microbiol. 7(7), 935–943 (2005).
   PubMed Web of Science ®Google Scholar
• Carter G, Wu M, Drummond DC, Bermudez LE. Characterization of biofilm formation by clinical isolates of Mycobacterium avium. J. Med. Microbiol. 52(Pt 9), 747–752 (2003).
   PubMed Web of Science ®Google Scholar
• George KM, Chatterjee D, Gunawardana G et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283(5403), 854–857 (1999).
   PubMed Web of Science ®Google Scholar
• Teng R, Dick T. Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm culture. FEMS Microbiol. Lett. 227(2), 171–174 (2003).
   PubMedGoogle Scholar
• McNabe M, Tennant R, Danelishvili L, Young L, Bermudez LE. Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials. Clin. Microbiol. Infect. 17(5), 697–703 (2011).
   PubMedGoogle Scholar
• Nguyen KT, Piastro K, Gray TA, Derbyshire KM. Mycobacterial biofilms facilitate horizontal DNA transfer between strains of Mycobacterium smegmatis. J. Bacteriol. 192(19), 5134–5142 (2010).
   PubMed Web of Science ®Google Scholar
• da Silva PE, Von Groll A, Martin A, Palomino JC. Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunol. Med. Microbiol. 63(1), 1–9 (2011).
   PubMedGoogle Scholar
• Colangeli R, Helb D, Vilchèze C et al. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis. PLoS Pathog. 3(6), e87 (2007).
   Google Scholar
• Vilchèze C, Av-Gay Y, Barnes SW et al. Coresistance to isoniazid and ethionamide maps to mycothiol biosynthetic genes in Mycobacterium bovis. Antimicrob. Agents Chemother. 55(9), 4422–4423 (2011).
   PubMedGoogle Scholar